Clinical trials
Phase 3 Bone Diseases, Metabolic trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2006 | 2 |
| 2009 | 1 |
| 2012 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 3 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Novartis | 1 |
| University Health Network, Toronto | 1 |
| University of Saskatchewan | 1 |
| Warner Chilcott | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bone Diseases, Metabolic | 8 |
| Osteoporosis | 6 |
| Bone Diseases | 2 |
| Musculoskeletal Diseases | 2 |
| Osteoporosis, Postmenopausal | 2 |
| Cataract | 1 |
| Crohn Disease | 1 |
| Neoplasms | 1 |
| Prostatic Neoplasms | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.